A novel therapeutic monoclonal antibody targeting PZR demonstrates potent antimetastatic efficacy in triple-negative breast cancer
Favorite
Share
More Options
23

Open in WPS to view all 23 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
